Search Within

Mark Weiss

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (18)
  3. Book Section (4)
Groups
  1. Center for Hematologic Malignancies (56)
  2. Department of Medicine (56)
  3. Hematologic Malignancies, Division of (56)
  4. Adult Leukemia (48)
  5. GSK Faculty (42)
  6. Hematologic Malignancies Research (42)

More Groups

People
  1. Peter Maslak (39)
  2. David Scheinberg (38)
  3. Joseph Jurcic (21)
  4. Nicole Lamanna (16)
  5. Ellin Berman (11)
  6. Mark Heaney (10)

More People

Years
  1. 2014 (1)
  2. 2010 (1)
  3. 2009 (2)
  4. 2008 (4)
  5. 2007 (1)
  6. 2006 (3)

More Years

Publications
  1. Blood (31)
  2. Journal of Clinical Oncology (7)
  3. Leukemia (5)
  4. Cancer (2)
  5. Cancer: Principles and Practice of Oncology. 5th ed (2)
  6. American Journal of Oncology Review (1)

More Publications

Publishers
  1. American Society of Hematology (31)
  2. American Society of Clinical Oncology (7)
  3. Nature Publishing Group (6)
  4. Lippincott Williams & Wilkins (2)
  5. Lippincott-Raven (2)
  6. Wiley Blackwell (2)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Enhanced in vivo activation of adoptively transferred genetically targeted T cells following cyclophosphamide chemotherapy: Initial results from a phase I clinical trial treating CLL patients with autologous CD19-targeted T cells
    Meeting Abstract

    Brentjens, R. J.; Hollyman, D.; Park, J.; Santos, E.; Yeh, R.; Stefanski, J.; Taylor, C.; Weiss, M. A.; Filippa, D.; Riviere, I.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19
    Meeting Abstract

    Brentjens, R. J.; Hollyman, D.; Weiss, M.; Stefanski, J.; Przybylowski, M.; Bartido, S.; Borquez-Ojeda, O.; Taylor, C.; Heaney, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Pentostatin in chronic lymphocytic leukemia
    Journal Article

    Sauter, C.; Lamanna, N.; Weiss, M. A.
    Expert Opinion on Drug Metabolism and Toxicology (2008)

    Fulltext@MSK | Save
  • Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion
    Journal Article

    Levin, T. T.; Cortes-Ladino, A.; Weiss, M.; Palomba, M. L.
    General Hospital Psychiatry (2008)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, rituximab, and mitoxantrone (PCRM): A new highly active regimen for patients with chronic lymphocytic leukemia (CLL) previously treated with PCR or FCR
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Brentjens, R. J.; Jurcic, J. G.; Weiss, M. A.
    Blood (2007)

    Fulltext@MSK | Save
  • High leveI T cell suppression following purine analog therapy for patients with CLL correlates with important clinical benefit
    Meeting Abstract

    Landau, H.; Lamanna, N.; Hobart, S.; Weiss, M. A.
    Blood (2006)

    Fulltext@MSK | Save